Numiera Therapeutics Revenue
Biotechnology Research • 
Denver, Colorado, United States • 1-10 Employees
$
Numiera Therapeutics revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Key Contacts at Numiera Therapeutics
Elizabeth Stoll
Chief Executive Officer
Megan Halloran
Director Of Communications
Company overview
| Headquarters | Denver, Colorado, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Drug Development, Brain Cancer, Glioblastoma |
| Founded | 2023 |
| Employees | 1-10 |
About Numiera Therapeutics
Numiera is on a mission to develop non-invasive small molecule therapies for glioblastoma patients by targeting cancer cell metabolism
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Entry
C-Suite
Director
Employees by Department
Numiera Therapeutics has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
Numiera Therapeutics has never raised funding before.
Spain
Canada
United Arab Emirates
Australia
Austria
New ZealandFrequently asked questions
Numiera Therapeutics is located in Denver, Colorado, US.
Numiera Therapeutics generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.
Numiera Therapeutics has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Numiera Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.
Numiera Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
